Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,927 shares at $28.20 ($139K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($139k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.20 | 2,222 | $63K | 45.0% |
| 2 | $28.20 | 2,222 | $63K | 45.0% |
| 3 | $28.59 | 483 | $14K | 9.9% |
| Total | $28.24 avg | 4,927 | $139K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |